Shimoi T - Search Results

1

Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study.

Kitadai R, Shimoi T, Sudo K, Noguchi E, Nagata Y, Sawada R, Takashima A, Boku N, Yonemori K. Kitadai R, et al. Among authors: shimoi t. BMC Cancer. 2021 Mar 20;21(1):294. doi: 10.1186/s12885-021-08025-x. BMC Cancer. 2021. PMID: 33743636 Free PMC article.

2

Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.

Odate T, Satomi K, Kubo T, Matsushita Y, Ueno T, Kurose A, Shomori K, Nakai T, Watanabe R, Segawa K, Ohshika S, Miyake N, Kudo S, Shimoi T, Kobayashi E, Komiyama M, Yoshimoto S, Nakatani F, Kawai A, Yatabe Y, Kohsaka S, Ichimura K, Ichikawa H, Yoshida A. Odate T, et al. Among authors: shimoi t. Mod Pathol. 2024 Jan;37(1):100359. doi: 10.1016/j.modpat.2023.100359. Epub 2023 Oct 21. Mod Pathol. 2024. PMID: 37871654

3

Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults.

Sasada S, Kodaira M, Shimoi T, Shimomura A, Yunokawa M, Yonemori K, Shimizu C, Fujiwara Y, Tamura K. Sasada S, et al. Among authors: shimoi t. Anticancer Res. 2016 May;36(5):2429-32. Anticancer Res. 2016. PMID: 27127153

4

Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer.

Bun S, Yunokawa M, Ebata T, Shimomura A, Shimoi T, Kodaira M, Yonemori K, Shimizu C, Fujiwara Y, Kato T, Makino Y, Hayashi Y, Tamura K. Bun S, et al. Among authors: shimoi t. Cancer Chemother Pharmacol. 2016 Oct;78(4):745-52. doi: 10.1007/s00280-016-3100-0. Epub 2016 Aug 13. Cancer Chemother Pharmacol. 2016. PMID: 27522647

5

Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas.

Ebata T, Yunokawa M, Bun S, Shimomura A, Shimoi T, Kodaira M, Yonemori K, Shimizu C, Fujiwara Y, Kato T, Tamura K. Ebata T, et al. Among authors: shimoi t. Cancer Chemother Pharmacol. 2016 Dec;78(6):1283-1288. doi: 10.1007/s00280-016-3187-3. Epub 2016 Nov 10. Cancer Chemother Pharmacol. 2016. PMID: 27832327

6

Amrubicin Monotherapy for Patients with Platinum-Pretreated Non-Gastrointestinal Non-Pancreatic Extrapulmonary Neuroendocrine Carcinoma.

Ebata T, Shimoi T, Ishiwata T, Iwasawa S, Bun S, Yunokawa M, Yonemori K, Takiguchi Y, Tamura K. Ebata T, et al. Among authors: shimoi t. Oncology. 2017;93(3):177-182. doi: 10.1159/000475669. Epub 2017 May 19. Oncology. 2017. PMID: 28521313

7

Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.

Yunokawa M, Yoshida H, Watanabe R, Noguchi E, Shimomura A, Shimoi T, Yonemori K, Shimizu C, Fujiwara Y, Tamura K. Yunokawa M, et al. Among authors: shimoi t. Cancer Chemother Pharmacol. 2017 Jul;80(1):127-134. doi: 10.1007/s00280-017-3342-5. Epub 2017 May 24. Cancer Chemother Pharmacol. 2017. PMID: 28540420

8

Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors.

Nishikawa T, Matsumoto K, Tamura K, Yoshida H, Imai Y, Miyasaka A, Onoe T, Yamaguchi S, Shimizu C, Yonemori K, Shimoi T, Yunokawa M, Xiong H, Nuthalapati S, Hashiba H, Kiriyama T, Leahy T, Komarnitsky P, Fujiwara K. Nishikawa T, et al. Among authors: shimoi t. Cancer Sci. 2017 Sep;108(9):1834-1842. doi: 10.1111/cas.13307. Epub 2017 Aug 5. Cancer Sci. 2017. PMID: 28665051 Free PMC article. Clinical Trial.

9

Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy.

Bun S, Yonemori K, Akagi T, Noguchi E, Shimoi T, Shimomura A, Yunokawa M, Shimizu C, Fujiwara Y, Makino Y, Hayashi Y, Tamura K. Bun S, et al. Among authors: shimoi t. Invest New Drugs. 2018 Feb;36(1):151-155. doi: 10.1007/s10637-017-0487-3. Epub 2017 Jul 21. Invest New Drugs. 2018. PMID: 28733700 Clinical Trial.

10

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer.

Kitano A, Ono M, Yoshida M, Noguchi E, Shimomura A, Shimoi T, Kodaira M, Yunokawa M, Yonemori K, Shimizu C, Kinoshita T, Fujiwara Y, Tsuda H, Tamura K. Kitano A, et al. Among authors: shimoi t. ESMO Open. 2017 May 2;2(2):e000150. doi: 10.1136/esmoopen-2016-000150. eCollection 2017. ESMO Open. 2017. PMID: 28761741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page